SHOX2 and RASSF1A methylation tests have diagnostic specificity and sensitivity in peripheral blood, alveolar lavage fluid, and tissue biopsy from lung cancer patients (12, 13), but their potential for screening and diagnosis of patients with early LUAD remains unclear. This evidence concerns the gene SHOX2 and lung carcinoma.